The Latest Breaking News on Pharma

Regeneron stock joined the 1,000-club this month as enthusiasm grows for its blockbuster drug, Dupixent, in COPD treatment.

Eli Lilly stock seesawed Tuesday after a Food and Drug Administration panel endorsed its Alzheimer's treatment, donanemab.

These five companies may offer higher earnings and return potential with lower risk. Two Leaderboard stocks included.

The biotech sector is primed for robust expansion fueled by the growing needs for personalized medicines and favorable government initiatives. Amid this backdrop, investors could consider buying biotech stocks Esperion Therapeutics (ESPR), Corcept Therapeutics (CORT), and Shionogi (SGIOY). Keep reading.

The share price recovery has been partly driven by the surge in wholesale energy prices, which is beyond his control

Viking Therapeutics stock falls despite seemingly positive test results for a drug that treats a serious liver disease.

BridgeBio stock gave up gains midday Tuesday after releasing a Phase 2 study on a growth disorder treatment.

Urban and rural communities have come to depend on pharmacies as a trusted care option and a place for advice

Eli Lilly is in a buy zone, while weight-loss drug rival Novo Nordisk just forged a lower entry.

The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.

French pharmacists began their first walkout in 10 years on Thursday, closing up shop over drug shortages, low regulated prices, pharmacy closures and fears medications could be sold online.